Stay updated on Telisotuzumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a phase 3 study comparing telisotuzumab vedotin with docetaxel for previously treated NSCLC, including eligibility, locations, outcomes, and data-sharing details.
    Difference
    100%
    Check dated 2026-11-11T01:21:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The study record remains unavailable behind a 403 Forbidden error page. The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:30:24.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the site navigation, and the displayed revision changes from v3.7.1 to v3.7.2. The page still shows a 403 error instead of the study record.
    Difference
    1%
    Check dated 2026-10-20T23:13:41.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision indicator changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:26:18.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Difference
    20%
    Check dated 2026-09-22T23:27:28.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now lists additional study sites and a Find contact information entry, signaling an expanded network of locations and updated access to study contacts for the trial.
    Difference
    0.1%
    Check dated 2026-09-15T22:21:36.000Z thumbnail image

Stay in the know with updates to Telisotuzumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page.